Hydroxy-9-methyl-2-Ellipticinium (NSC 264-137) in 52 cases of osseous metastases from breast cancer.
D000470:Alkaloids / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002113:Calcification, Physiologic; D002986:Clinical Trials as Topic; D004611:Ellipticines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged
D000470:Alkaloids; D004611:Ellipticines; C027767:elliptinium